Martin Dreyling

27PUBLICATIONS
300CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL.

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Jul 07, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

|Jul 01, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agent.

|Jun 23, 2026
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.

Pageof 5

Frequent Collaborators

7 joint publications

Eva Hoster

6 joint publications

Gilles Salles

5 joint publications

David W Scott

4 joint publications

Pier-Luigi Zinzani